Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2015 | 06-2014 | 06-2007 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,413 | N/A | N/A |
| Accounts payable and accrued liabilities | -48 | N/A | N/A |
| Other Working Capital | -31 | N/A | N/A |
| Other Operating Activity | 2,065 | 0 | 0 |
| Operating Cash Flow | $-1,427 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -4 | N/A | N/A |
| Other Investing Activity | -2 | 0 | 0 |
| Investing Cash Flow | $-6 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 1,439 | N/A | N/A |
| Debt Repayment | -29 | N/A | N/A |
| Common Stock Issued | 29 | N/A | N/A |
| Other Financing Activity | -157 | 0 | 0 |
| Financing Cash Flow | $1,282 | $N/A | $N/A |
| Exchange Rate Effect | 170 | N/A | N/A |
| Beginning Cash Position | 88 | N/A | N/A |
| End Cash Position | 108 | N/A | N/A |
| Net Cash Flow | $20 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,427 | N/A | N/A |
| Capital Expenditure | -4 | N/A | N/A |
| Free Cash Flow | -1,430 | 0 | 0 |